Trulieve Cannabis (NYSE:TRLV) CEO Sells 300,000 Shares

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 300,000 shares of the stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $8.17, for a total transaction of $2,451,000.00. Following the transaction, the chief executive officer owned 1,613,724 shares of the company’s stock, valued at $13,184,125.08. The trade was a 15.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Trading Up 0.7%

TRLV stock traded up $0.06 during midday trading on Thursday, hitting $8.56. The company’s stock had a trading volume of 2,007,316 shares, compared to its average volume of 576,130. Trulieve Cannabis Corp. has a twelve month low of $3.50 and a twelve month high of $13.28.

Analyst Ratings Changes

Several research analysts recently commented on TRLV shares. Weiss Ratings initiated coverage on Trulieve Cannabis in a research report on Tuesday, June 16th. They set a “sell (d-)” rating for the company. Zacks Research raised Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Reduce”.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.